	Engineering strategies and therapeutic applications of synthetic Notch (synNotch) receptors in cancer therapeutics. Drug Discov Today Gholap AD, Vengurlekar JR, Hatvate NT, Thorat ND. PMID: 41672235 [PubMed - as supplied by publisher]
	From Diagnosis, Therapy Decision-Making to Genetic Risk Assessment: The Impact of ctDNA Testing on Comprehensive Cancer Management-A Case Report. J Natl Compr Canc Netw Kanwar N, Seyi AB, Tan N, Rojas C, Ernani V, Rumilla KM, Borad MJ, Zheng G. PMID: 41671451 [PubMed - indexed for MEDLINE]
	Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter? J Natl Compr Canc Netw Tan PH, Thiels CA, Poruk K, Miller RM, Hor HY, Tu MPY, Huyser MR, Stucky CC, Wasif N, Bold RJ, Smoot RL, Starlinger PP, Warner SG, Kendrick ML, Stauffer JA, Truty MJ, Fong ZV, Mayo Clinic Enterprise HPB Disease Group. PMID: 41671431 [PubMed - indexed for MEDLINE]
	NCCN GuidelinesÂ® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026. J Natl Compr Canc Netw Cheng HH, Giri VN, Goggins M, Yurgelun MB, Karlan BY, Norquist BS, Daly MB, Pal T, AlHilli Z, Arun B, Churpek J, Colonna S, Domchek SM, Escobar MR, Fejerman L, Friedman S, Hagemann A, Hendrix A, Huo D, Hutton ML, Kassem N, Khan S, Kurian AW, Laronga C, Mak JS, Maxwell KN, McDonnell K, Merajver SD, Mersch J, Offit K, Plichta J, Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Welborn J, Wick MJ, Wood M, Darlow S, Diwan Z, Dwyer M. PMID: 41671423 [PubMed - indexed for MEDLINE]
	Mechanisms of simplified sitting Badunjin effects on symptom burden: a network-based cross-lagged analysis in advanced cancer patients. Support Care Cancer Zheng J, Zou H, Lu Y, Chen L, Zheng M, Zhu Z, Cheng W, Xiao H. PMID: 41670735 [PubMed - indexed for MEDLINE]
	Combined hematology, tumor morphology, and magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma: a clinical study. Quant Imaging Med Surg Bei HY, Kang ZJ, Zhong M, Liu CF, Yan KL, Tan XY, Dan Y, Wu JY, Yang YG. PMID: 41669472 [PubMed]
	Integrated multi-omics, spatial profiling and organoid modeling drive transformative advances in chronic liver disease and hepatocellular carcinoma immunomicroenvironment research. Front Immunol Liu Q, Wang C, Ye C, Zhang H, Li T, Wei W, Wang S, Zhang H. PMID: 41668742 [PubMed - indexed for MEDLINE]
	Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment. Cancer Rep (Hoboken) Kai Y, Ikezawa K, Kozumi K, Urabe M, Takada R, Kinomoto T, Masumoto T, Kawabata M, Kishimoto H, Hosokawa K, Mukai K, Nakabori T, Yamaguchi Y, Sugimoto N, Ohkawa K. PMID: 41668632 [PubMed - indexed for MEDLINE]
	Exogenous-Label-Free Colorimetric/SERS Dual-Mode Immunosensing Platform Driven by Au NCs@Pt Nanozyme for Ultrasensitive and Rapid Detection of the Pancreatic Cancer Biomarker CA19-9. Anal Chem Qi QJ, Xu Z, Yu YF, Guan PC, Lin JS, Zhou JW, Wu Y, Zheng S, Zhang YJ, Li JF. PMID: 41668424 [PubMed - as supplied by publisher]
	Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A). BMC Cancer Sano Y, Kajikawa R, Mizusawa J, Ioka T, Ozaka M, Nakamura S, Ito Y, Furuse J, Kobayashi S, Fukuda H, Okusaka T, Ikeda M, Miwa H, Sasahira N, Nagashima F, Ohkawa K, Yamazaki K, Kanai M, Yamashita T, Hara K, Takayama Y, Komatsu Y, Fujimori N, Hama N, Kamata K, Hisano T, Shimizu S, Tobimatsu K, Maeda S, Ueno M. PMID: 41668051 [PubMed - as supplied by publisher]
	Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. Nat Commun Huff AL, Haldar SD, Gergis AA, Wang HH, Danilova L, Heumann T, Berg M, Wang Y, Andaloori L, Hernandez A, Longway G, Barrett B, Zhu Z, Davis-Marcisak E, Thoburn C, Leatherman J, Mitchell S, Lee JW, Shu DH, Konig MF, Mog BJ, Montagne J, Coyne EM, Bever K, Baretti M, Yarchoan M, Anders RA, Kagohara LT, Laheru D, Thomas AM, Durham J, Nauroth JM, Lu J, Wang H, Fertig EJ, Ho WJ, Azad NS, Jaffee EM, Zaidi N. PMID: 41667470 [PubMed - indexed for MEDLINE]
	Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study. J Immunother Cancer Piao M, Li C, Li S, Zhang N, Li J, Luo X, Liu R, Wang F, Shi X, Liu C, Tan G, Zhu Z, Yang X, Zhao H. PMID: 41667152 [PubMed - indexed for MEDLINE]
	Cytokine circuitry in pancreatic cancer: Targets for overcoming immune checkpoint inhibitor resistance in PDAC. Cytokine Growth Factor Rev Suresh DS, Salcedo-Noriega MF, Vaish U, Kannan AB, Suryansh S, Bhandari S, Chatre S, Jain T, Dudeja V, Iyer S. PMID: 41666756 [PubMed - as supplied by publisher]
	microRNAs in pancreatic cancer: Key modulators of tumor progression and therapeutic resistance. Biomed Pharmacother Sadeghi H, Kohkalani M, Seyyed Rezaei SA, Kargarmonhaser S, Mahd Gharebagh F, Nikdouz A, Hosseini A. PMID: 41666513 [PubMed - as supplied by publisher]
	Re-evaluating the diagnostic value of Î±-fetoprotein for hepatocellular carcinoma in the direct-acting antiviral era. Cancer Takeda Y, Imamura H, Ichida H, Yoshioka R, Mise Y, Saiura A. PMID: 41665927 [PubMed - indexed for MEDLINE]
	Robotic Secondary Cytoreductive Surgery: A Personalized Surgical Approach For a Triple-Site Ovarian Cancer Recurrence. Ann Surg Oncol Certelli C, Meacci E, Oliva R, Mastrovito S, Penza V, Calabrese G, Dolciami M, Bruno M, Fagotti A, Gallotta V. PMID: 41665786 [PubMed - as supplied by publisher]
	Comparison of supine and upright postures in carbon ion radiotherapy for pancreatic cancer: An in silico planning study. Med Phys Nomura Y, Inaniwa T, Isozaki T, Kurosaki H, Shinoto M, Yamada Y, Yamada M, Yokoyama Y, Mizuno H, Yonai S, Iwata Y, Takeda A, Ishikawa H, Jinzaki M. PMID: 41665561 [PubMed - indexed for MEDLINE]
	Identifying Bridge Symptoms Linking Physical and Psychological Burdens in Postoperative Pancreatic Cancer Patients: A Network Analysis. Psychooncology Song Y, Jin S, Li L, Li Z, Liu Y, Liu J, Zhuang S. PMID: 41665518 [PubMed - indexed for MEDLINE]
	Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancer. Front Oncol Chen J, Zou L, Bai X, Tong F, Ni J, Tang H, Liu Y, Kong X, Yin J, Wang F, Sha H, Meng F, Du J. PMID: 41659718 [PubMed]
	Decoding the microbial blueprint of pancreatic cancer. Front Med (Lausanne) Bautista J, Bedón-Galarza R, Martínez-Hidalgo F, Masache-Cruz M, Benítez-Núñez M, Valencia-Arroyo C, López-Cortés A. PMID: 41658610 [PubMed]

Articles 1 - 20 / 59027

Page 1 of 2952



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy